Publications

Strategic Consulting / Expert Panels

  • Munro MG, Critchley HOD, Broder MS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. J Gynaecol Obstet. 2011;113(1):3-13
    Click to request

  • Woolcock JG, Critchley HOD, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding [published online ahead of print February 5 2008]. Fertil Steril 2008.doi:10.1016/j.fertnstert.2007.10.060
    Click to request

  • Fraser IS, Critchley HOD, Munro MG, Broder MS. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007;87(3):466-476.
    Click to request

  • Fraser IS, Critchley HOD, Munro MG, Broder MS. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007;22(3):635-643.
    Click to request

  • The Society for the Advancement of Blood Management. The cost of blood: multidisciplinary consensus conference for a standard methodology. Transfus Med Rev. 2005;19(1):66-78.
    Click to request

  • Hanley D, Gorelick PB, Elliott WJ, et al. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group in recurrent stroke prevention. J Stroke Cerebrovasc Dis. 2004;13(5):196-207.
    Click to request

  • Broder M, Oken C, Parker M, Giammona M, Newman J, Harrington C, Rubenstein L. Outpatient Care: A Conceptual Framework And A Form For Structured Implicit Review, Santa Monica, Calif.: RAND, MR-1258, Aug 2001.
    Click to request

  • Broder MS, Landow WJ, Goodwin SC, Brook RH, Sherbourne CD, Harris K. An agenda for research into uterine artery embolization: results of an expert panel conference. J Vasc Interv Radiol. 2000;11(4):509-515.
    Click to request

  • Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet Gynecol. 2000;95(2):199-205.
    Click to request

  • Broder MS, Rubenstein LV. Complaints About Quality Of Care: A Structured Implicit Review, Santa Monica, Calif.: RAND, DRU-2638, May 1999.

  • Broder MS, Rubenstein LV. Complaints About Quality Of Care: Guidelines For Structured Implicit Review, Santa Monica, Calif.: RAND, DRU-2639, Apr 1999.

Health Economics

  • Poston S, Broder MS, Gibbons MM, MacLaren R, Chang E, VandePol CJ, Cook SF, Techner L. The impact of alvimopan on hospital cost after bowel resection: Results from a large in-patient database. P&T 2011;209-220.
    Click to request

  • Broder MS, Chang EY, Bentley TGK, Juday T, Uy J. Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naive human immunodeficiency virus-infected patients in the United States. J Med Econ. 2010;14(2):167-178.
    Click to request

  • Bentley TGK, Weinstein MC, Willett WC, Kuntz KM. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 2009;12(4):455-467.
    Click to request

  • Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal A. Cost and utilization of COPD and asthma among insured adults in the US. Curr Med Res Opin. 2009;25(6):1385-1392.
    Click to request

  • Bentley TGK, Aledort J, Effros R, et al. Waste in the U.S. health care system: framework and overview. Milbank Q. 2008;86(4):629-659.
    Click to request

  • Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population. J Manag Care Pharm. 2008;14(2):176-185.
    Click to request

  • Wade SW, Magee G, Metz L, Broder MS. Cost-effectiveness of treatments for dysfunctional uterine bleeding. J Reprod Med. 2006;51(7):553-562.
    Click to request

  • Bentley T, Willett W, Weinstein M, Kuntz K. Evaluating the U.S. folic acid fortification policy: did we succeed? Med Decis Making. 2005;25(1):E20.
    Click to request

  • Chen K, Chang EY, Summers KH, Obenchain RL, Yu-Isenberg KS, Sun P. Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care setting. J Manag Care Pharm. 2005;11(5):376-382.
    Click to request

  • Ory C, Vanderplas A, Dezii C, Chang E. An economic analysis of healthcare utilization among patients with congestive heart failure compared to those without congestive heart failure within a managed care organization. J Pharmaceut Finance Econ Pol. 2005;14:87-97.
    Click to request

  • Yu-Isenberg KS, Vanderplas A, Chang EY, Shah H. Utilization and medical care expenditures in patients with chronic obstructive pulmonary disease: a managed care claims data analysis. Dis Manage Health Outcomes. 2005;13(6):405-412.
    Click to request

  • White TJ, Vanderplas A, Change E, Dezii CM, Abrams GD. The costs of non-adherence to oral antihyperglycemic medication in individuals with diabetes mellitus and concomitant diabetes mellitus and cardiovascular disease in a managed care environment. Dis Manage Health Outcomes. 2004;12(3):181-188.
    Click to request

  • Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004;27(9):2129-2134.
    Click to request

  • Malkin JD, Keeler E, Broder MS, Garber S. Postpartum length of stay and newborn health: a cost-effectiveness analysis. Pediatrics. 2003;111:e316-e322.
    Click to request

  • Bentley TGK. The benefits and risks of folic acid fortification. Harvard Health Policy Review. Vol. 4, No. 2. Fall 2003.
    Click to request

  • White TJ, Vanderplas A, Ory C, Dezii CM, Chang E. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Health Outcomes. 2003;11(12):817-822.
    Click to request

  • Chen KS, Melikian C, Chang E, White TJ. A retrospective analysis of short-term costs and utilization associated with glycemic control among patients diagnosed with type 2 diabetes within a managed care organization [abstract]. Value Health. 2002;5(3):206.
    Click to request

Outcomes Research

  • Bentley TGK, Palta M, Paulsen A, et al. Race and gender associations between obesity and nine health-related quality-of-life measures. Qual Life Res. In press.
    Click to request

  • Broder M, Juday T, Chang E, Jing Y, Bentley T. Using administrative claims data to estimate virologic failure rates among human immunodeficiency virus-infected patients with antiretroviral regimen switches. Med Decis Making. In press.
    Click to request

  • Broder MS, Chang EY, Kamath T, Sapra S. Poor disease control among insured users of high-dose combination therapy for asthma. Allergy Asthma Proc. 2010;31(1):60-67.
    Click to request

  • Broder MS, Chang EY, Sapra S. Care of asthma patients in relation to guidelines. Allergy Asthma Proc. 2010;31(6):452-460.
    Click to request

  • Broder MS, Gutierrez B, Chang E, Meddis D, Schatz M. Ratio of controller to total asthma medications: determinants of the measure. Am J Manag Care. 2010;16(3):170-178.
    Click to request

  • Broder M, Chang E, Ory C, Kamath T, Sapra S. Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population. [published online ahead of print January 16, 2009]. Allergy Asthma Proc. 2009;30:148-157. doi: 10.2500/aap.2009.30.3190.
    Click to request

  • Lorenz KA, Krebs EE, Bentley TGK, et al. Exploring alternative approaches to routine outpatient pain screening. Pain Med. 2009;10(7):1291-1299.
    Click to request

  • Schatz M, Broder M, Chang E, O'Connor R, Luskin A, Solari PG. Asthma quality-of-care measures using administrative data: identifying the optimal denominator. Ann Allergy Asthma Immunol. 2009;102(2):98-102.
    Click to request

  • Parker WH, Broder MS, Chang E, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study. Obstet Gynecol. 2009;113(5):1027-1037.
    Click to request

  • Delaney CP, Chang E, Senagore AJ, Broder M. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database. Ann Surg. 2008;247(5):819-824.
    Click to request

  • Keystone E, Burmester GR, Furie R, et al. Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy. Arthritis Rheum. 2008;59(6):785-793.
    Click to request

  • Bentley TGK, Willett WC, Weinstein MC, Kuntz KM. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health. 2006;96(11):2040-2047.
    Click to request

  • Parker WH, Broder MS, Berek JS. Hysterectomy sans oophorectomy: the case for leaving a woman's ovaries alone. Contemporary Ob/Gyn. July 2006.
    Click to request

  • Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106(2):219-226.
    Click to request

  • Lew KH, Chang EY, Rajagopalan K, Knoth, RL. The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface. 2006;19(9):41-46.
    Click to request

  • Ory C, Fontes C, Williams SA, Borok G, McDonough K, Chang E. An evaluation of the factors associated with statin dose management and low-density lipoprotein-cholesterol goal attainment. Dis Manag Health Outcomes. 2006;14(1):37-44.
    Click to request

  • Broder MS, Spalding J. Treatment patterns for women with new episodes of uterine myomas in an insured population in the US. Current Med Res Opin. 2006;22(1):95-100.
    Click to request

  • Broder MS, Payne-Simon L, Brook RH. Measures of surgical quality: what will patients know by 2005? J Eval Clin Prac. 2005;11(3):209-217.
    Click to request

  • Stockl K, Cyprien L, Chang EY. Gastrointestinal bleeding rates among managed care patients newly started on COX-2 inhibitors or nonselective NSAIDs. J Manag Care Pharm. 2005;11(7):550-558.
    Click to request

  • Wallis RS, Broder M, Wong J, Lee A, Hoq L. Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis. 2005:41(suppl 3):S194-S198.
    Click to request

  • Asch SM, Baker DW, Keesey JW, et al. Does the collaborative model improve care for chronic heart failure? Med Care. 2005;43(7):667-675.
    Click to request

  • Morikawa BH, Vanderplas AM, Chang EY, Lew KH. NSAID utilization patterns following market withdrawal of rofecoxib. Formulary. 2005;40:220-226.
    Click to request

  • Broder MS, Payne Simon L, Brook RH. Surgical quality: review of Californian measures. Br Med J. 2004;328(7432):152-153.
    Click to request

  • Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis. 2004;38(9):1261-1265.
    Click to request

  • Broder MS, Bovone S. Improving treatment outcomes with a clinical pathway for hysterectomy and myomectomy. J Reprod Med. 2002;47(12):999-1004.
    Click to request

  • White TJ, Chang E, Leslie S, et al. Patient adherence with HMG reductase inhibitor therapy among users of two types of prescription services. J Manag Care Pharm. 2002;8(3):186-191.
    Click to request

  • Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol. 2002;100(5):864-868.
    Click to request

  • Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Therapeut. 2002;24(3):460-467.
    Click to request

  • Berland GK, Morales LS, Elliott MN, et al. Health information on the Internet: accessibility, quality, and readability in English and Spanish. JAMA. 2001;285(20):2612-2621.
    Click to request

  • Broder MS, Kanouse DE, Bernstein SJ. Assessing symptoms before hysterectomy: is the medical record accurate? Am J Obstet Gynecol. 2001(1);185:97-102.
    Click to request

  • Berland GK, Morales LS, Elliott MN, et al. Proceed with caution: a report on the quality of health information on the Internet. California HealthCare Foundation, May 2001.
    Click to request

  • Malkin JD, Garber S, Broder MS, Keeler E. Infant mortality and early postpartum discharge. Obstet Gynecol. 2000;96(2):183-188.
    Click to request

  • Malkin JD, Broder MS, Keeler E. Do longer postpartum stays reduce newborn readmissions? Analysis using instrumental variables. Health Serv Res. 2000;35(5 Pt 2):1071-1091.
    Click to request

  • Prendergast ML, Podus D, Chang E. Program factors and treatment outcomes in drug dependence treatment: an examination using meta-analysis. Subst Use Misuse. 2000;35(12-14):1931-1965.
    Click to request

  • Broder MS, Oken C, Rubenstein LV. Medicare Beneficiary Alternative Methods Study, Module II. HCFA Report 500-96-P535, October, 1999.

  • Broder MS, Harris K, Morton S, Sherbourne C, Brook R. Uterine Artery Embolization: A Systematic Review Of The Literature And Proposal For Research, Santa Monica, Calif.: RAND, MR-1158, Aug 1999.
    Click to request

Books and Book Chapters

  • Broder M. The Panic-Free Pregnancy. New York, New York: Perigee Books; 2004.
    order through Amazon

  • Goodwin S, Broder M, Drum D. What Your Doctor May Not Tell You About Fibroids. New York, New York: Warner Books; 2003.
    order through Amazon

  • Broder MS. Gynecologic procedures. In: Hacker N, Moore JG, Gambone JG, eds. Essentials of Gynecology. New York, New York: WB Saunders; 2004.
    order through Amazon

  • Broder M. Benign disorders of the uterine corpus. In: DeCherney AH, Nathan L, eds. Current Obstetric & Gynecologic Diagnosis & Treatment. 9th ed. New York, New York: McGraw-Hill; 2002.
    order through Amazon

  • Broder M. Uterine fibroids. In: Pregler JP, DeCherney AH, eds. Women's Health: Principles and Practice. Hamilton, Ontario, Canada: BC Decker, Inc.; 2002.
    order through Amazon

Other

  • Oratz R, Kim B, Chao C, et al. Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive and estrogen receptor-positive breast cancer. J Oncol Pract. In press.
    Click to request

  • Bentley TGK, Kuntz KM, Ringel JS. Bias associated with failing to incorporate dependence event history in Markov models. Med Decis Making. 2010;30(6):651-660.
    Click to request

  • Bentley TGK, Weinstein MC, Kuntz KM. Effects of categorizing continuous variables in decision-analytic models. Med Decis Making. 2009;29(5):549-556.
    Click to request

  • Bentley TGK, Caulkins JP, Pacula RL, Paddock MS. Using microsimulation modeling to capture heterogeneity in lifetime illicit drug use. Med Decis Making. 2008;28. Abstract author index, data supplement P4-13.
    Click to request

  • Broder MS, Gambone JC. Abnormal uterine bleeding during the reproductive years - terminology and treatment. US Obstetrics and Gynecology. 2008;3(2):17-20
    Click to request

  • Broder MS, Reissman D. A method for classifying biologics for formulary decision making. Manag Care Interface. 2006;19(4):30-32.
    Click to request

  • Furst DE, Wallis R, Broder M, Beenhouwer DO. Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection. Semin Arthritis Rheum. 2006;36(3):159-167.
    Click to request

  • Beenhouwer D, Wallis R, Broder M, Furst DE. Mechanisms of action of tumor necrosis factor antagonists and granulomatous infections. J Rheum. 2004;31(10):1888-1892.
    Click to request

  • Broder MS. The active management of labor: is it worth the cost? West J Med. 2000;172(4):243-244.
    Click to request

  • Broder MS. Early experiences with a clinical pathway for hysterectomy and myomectomy. J Gynecol Tech. 1998;4:55-59.
    Click to request

Back to top Back to top
280 S. Beverly Dr., Suite 404, Beverly Hills, CA 90212     |     Phone: 310-858-9555     |     Fax: 310-858-9552     |     info@pharllc.com
Publications